Regulatory Oversight or Lack of Foresight? Implications for Product Recall Policies and Procedures
The regulatory effectiveness, the impact on industry and consumers of product withdrawal and the associated wider issues relating to crisis management represent an under-researched area. The authors describe the mid-2003 government-ordered withdrawal of almost 2,000 complementary and alternative medicines, across multiple brand names, in Australia and New Zealand. The report is based on an examination of the media coverage of the event and on interviews with key informants in manufacturing and retailing and the regulatory system. This massive, multi-brand recall provides an opportunity to examine the effectiveness and efficiency of the management of a cross-border withdrawal from regulatory and consumer policy perspectives and makes recommendations for the management of future recall events. Copyright Springer 2005
When requesting a correction, please mention this item's handle: RePEc:kap:jcopol:v:28:y:2005:i:4:p:433-460. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Guenther Eichhorn)or (Christopher F. Baum)
If references are entirely missing, you can add them using this form.